IP Library › Assignment 072171/0946

Patent Assignment

Reel/Frame 072171/0946

Assignment of Assignor's Interest

Recorded: 2025-09-05 Pages: 6

View PDF Order Certified Copy

Assignors

EL-KATTAN, YAHYA

Executed: 2019-12-03

BABU, YARLAGADDA S.

Executed: 2019-12-03

Assignee

BIOCRYST PHARMACEUTICALS, INC.

4505 EMPEROR BLVD., SUITE 200, DURHAM, NORTH CAROLINA, 27703

Covered Properties (6)

Crystalline Salts of a Plasma Kallikrein Inhibitor

Patent: 12,545,645 →

Application: 19/312,645 →

Publication: US 2025/0388546

Crystalline Salts of a Plasma Kallikrein Inhibitor

Patent: 12,552,750 →

Application: 19/312,656 →

Publication: US 2025/0376447

Crystalline Salts of a Plasma Kallikrein Inhibitor

Patent: 12,545,646 →

Application: 19/312,755 →

Publication: US 2025/0388547

Crystalline Salts of a Plasma Kallikrein Inhibitor

Patent: 12,545,647 →

Application: 19/312,786 →

Publication: US 2025/0388548

Crystalline Salts of a Plasma Kallikrein Inhibitor

Patent: 12,590,068 →

Application: 19/313,010 →

Publication: US 2025/0388549

Crystalline Salts of a Plasma Kallikrein Inhibitor

Patent: 12,590,069 →

Application: 19/313,046 →

Publication: US 2025/0376448

Related Assignments (2)

Other recorded transfers of the patents in this record — the chain of ownership.

Assignment of Assignor's Interest Jan 12, 2026

From: EL-KATTAN, YAHYA; BABU, YARLAGADDA S.

To: BIOCRYST PHARMACEUTICALS, INC.

Reel/Frame 073440/0481 →

Security Interest Jan 23, 2026

From: BIOCRYST PHARMACEUTICALS, INC.

To: WILMINGTON TRUST, NATIONAL ASSOCIATION

Reel/Frame 074485/0651 →